I agree that Sanofi Rare Blood Disorders and its agents (such as
third-party business partners) can contact me by mail, email, fax and/or
telephone, including calls and text messages, and send me information
about rare blood disorders and relevant Sanofi products,
promotions, services, and research studies, ask my opinion about such
information and topics, including through market research and
disease-related surveys, and share the information I provide with one
another to perform these activities, and to de-identify it for use in
performing research, education, business analytics, marketing studies, and
other commercial purposes. I understand that text messaging rates may
apply. Your information will not be sold to any third party but may be
provided to regulatory authorities if required. You may have certain
rights under applicable data privacy laws regarding your personal
information, including the right to access your personal information held
by Sanofi. For further information regarding these rights, please
This site is intended for U.S.
© 2022 Genzyme Corporation. All rights reserved.
Sanofi is a registered trademark of Sanofi or an affiliate.
All other trademarks are the property of their respective owners.
MAT-US-2107338 v3.0 09/2022